⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ICU News
SeaStar Medical Holding Corporation Common Stock
SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI
globenewswire.com
ICU
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
globenewswire.com
ICU
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
globenewswire.com
ICU
Form 8-K
sec.gov
ICUCW
ICU
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
globenewswire.com
ICU
SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
globenewswire.com
ICU
New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)
globenewswire.com
ICU
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
globenewswire.com
ICU
SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
globenewswire.com
ICU
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
globenewswire.com
ICU